Table 3.
Association between demographic, clinical, paraclinical data, and vaccination status with patient mortality
| variable | Death | p.value | |||
|---|---|---|---|---|---|
| Yes | No | ||||
| Age | Mean(SD) | 61.33(50.49) | 57.55(17.57) | 0.077** | |
| Sex, N (%) | Male | 32 (13.4) | 248 (88.6) | 0.204* | |
| Female | 50 (14.9) | 285 (85.1) | |||
| BMI, N (%) | < 30 | 57 (10.4) | 368 (86.6) | 0.932* | |
| > 30 | 25 (13.4) | 165 (86.6) | |||
| Diabetes, N (%) | Yes | 58 (30.9) | 130 (69.1) | < 0.0001* | |
| No | 40 (5.6) | 403(64.4) | |||
| Hypertension, N (%) | Yes | 59(24.3) | 184(75.7) | < 0.0001* | |
| No | 23(6.2) | 349(93.8) | |||
| Ischemic heart disease, N (%) | Yes | 37 (38.1) | 60(61.9) | < 0.0001* | |
| No | 45(8.7) | 473(91.3) | |||
| Dyslipidemia, N (%) | Yes | 19 (13.3) | 124 (86.7) | 0.985* | |
| No | 63 (13.3) | 409 (86.7) | |||
| CKD, N (%) | Yes | 11(14.3) | 66(85.7) | 0.793* | |
| No | 71(13.2) | 467(86.8) | |||
| COPD, N (%) | Yes | 5 (19.2) | 21 (80.8) | 0.366* | |
| No | 77 (13.1) | 512 (86.9) | |||
| Hypothyroidism, N (%) | Yes | 7(17.5) | 33 (82.5) | 0.423* | |
| No | 75 (13.0) | 500 (87.0) | |||
| CVA, N (%) | Yes | 4 (36.4) | 7 (63.6) | 0.023* | |
| No | 78 (12.9) | 526 (87.1) | |||
| Cancer, N (%) | Yes | 3(23.1) | 10(76.9) | 0.296* | |
| No | 79 (13.1) | 523 (86.9) | |||
| Vaccination status, N (%) | complete | 10(3) | 320(97) | < 0.0001* | |
| incomplete | 72(25.3) | 213(74.7) | |||
| Score of lung involvement at baseline, N (%) | 0–8 | 14 (3.2) | 425(96.8) | < 0.0001* | |
| 9–16 | 43(23.9) | 101(70.8) | |||
| 17–25 | 25(78.1) | 7(21.8) | |||
| CRP, N (%) | Negative | 20(15) | 113(85) | 0.075* | |
| + | 9(7.1) | 117(92.9) | |||
| ++ | 33(17) | 161(83) | |||
| +++ | 20(12.3) | 142(87.7) | |||
| Intubation, N (%) | Yes | 60(89.6) | 7(10.4) | < 0.0001* | |
| No | 22(4) | 526(96) | |||
| ICU admission, N (%) | Yes | 62(56.4) | 48(43.6) | < 0.0001* | |
| No | 20(4) | 485(96) | |||
| Vaccine type, N (%) | Inactive | 19(5.6) | 322(94.4) | 0.633* | |
| viral vector | 5(9.6) | 47(90.4) | |||
| Recombinant proteins | 0 | 3(100) | |||
| Recombinant proteins + inactive | 0 | 12(100) | |||
| viral vector + inactive | 0 | 4(100) | |||
| ESR | 51.36(30.92) | 45.15(29.66) | 0.08** | ||
| Mean(SD) | |||||
| NLR | 13.37(8.53) | 6.23(5.39) | < 0.0001** | ||
| ICU length of stay,y | 5.75 (4.23) | 4.96 (3.47) | 0.30** | ||
| hospital length of stay,y | 7.91(6.27) | 5.30(2.18) | < 0.0001** | ||
N: Number; BMI: Body Mass Index; y: year, SD:standard deviation, CKD: Chronic kidney disease, COPD: Chronic Obstructive Pulmonary Disease, CVA: Cerebrovascular accident, CRP:C Reactive protein, NLR: Neutrophil-Lymphocyte Ratio ESR: Erythrocyte Sedimentation Rate, ICU: Intensive Care Unit,
*:Chi-square test, **: student’s t-test